Global Footprint

About MOONRAKER
Meet Our Team
- Executive Committee
- Steering Committee
Health Resources
Contact

Participating countries

31 countries • 5 continents • one global team

MOONRAKER is a series of three complementary pragmatic Phase III trials investigating the role of finerenone in real-world heart failure populations across the ejection fraction spectrum and range of clinical presentations.

Useful Links

Contact Us

About MOONRAKER
- Single Course
Meet Our Team
Blog
Styles
Contact